FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2107255073> ?p ?o ?g. }

• W2107255073 endingPage "76" @default.
• W2107255073 startingPage "76" @default.
• W2107255073 abstract "Autoimmune joint diseases occur due to uncontrolled abnormal immune responses (autoimmunity). The commonest autoimmune diseases seen in clinical practice are rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and un-differentiated arthritis. These are a source of significant morbidity and some mortality within the population. Non-biologic disease modifying anti-rheumatic drugs (Nonbiologic DMARD’s) commonly used in the treatment of these disorders include: methotrexate, sulpha-salazine, leflunomide, hydroxychloroquine and gold. However, a significant proportion of patients do not show adequate responses to these agents. The last few years has seen the introduction of a class of drugs directed at specific patho-physiological abnormalities identified in these diseases. These drugs have not only brought the promise of better response rates but also the possibility of a cure for some patients. These agents are called biologic disease modifying anti-rheumatic drugs (biologic-DMARDS). Biologic-DMARDS show better response rates and appear to be well tolerated by patients. Currently, the biologic- DMARDS are mainly used in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthropathy. The currently approved biologics for autoimmune diseases are: TNF alpha antagonists (Infliximab, Etanercept, Adalimumab, and Golimumab), IL-1 antagonists (Anakinra), anti CD-20 antibodies (Rituximab), IL-6 antagonists (Tocilizumab) and the T-cell inhibitor (Abatacept). Recently, increased rates of infection have been reported and the long-term safety profiles of the biologic-DMARDS are still unknown. Due to these problems coupled with the prohibitive costs, the exact place of these agents within treatment algorithms is still been defined. In many developed countries these agents are now included in the management with provision of specific guidance on when and how to use them. Our review outlines important pharmacological and clinical aspects of these agents in the treatment of autoimmune joint diseases. DOI: http://dx.doi.org/10.4038/jccp.v41i2.3770   Journal of the Ceylon College of Physicians, 2010, 41, 76-82" @default.
• W2107255073 created "2016-06-24" @default.
• W2107255073 creator A5054022162 @default.
• W2107255073 creator A5080471651 @default.
• W2107255073 creator A5083389526 @default.
• W2107255073 creator A5089092128 @default.
• W2107255073 date "2011-11-02" @default.
• W2107255073 modified "2023-09-28" @default.
• W2107255073 title "Biologics: a new weapon in the war against autoimmune joint disease" @default.
• W2107255073 cites W1545872915 @default.
• W2107255073 cites W1591357179 @default.
• W2107255073 cites W1898024773 @default.
• W2107255073 cites W1981146427 @default.
• W2107255073 cites W1988995773 @default.
• W2107255073 cites W1989198058 @default.
• W2107255073 cites W1990990544 @default.
• W2107255073 cites W1999777294 @default.
• W2107255073 cites W2008925400 @default.
• W2107255073 cites W2016193783 @default.
• W2107255073 cites W2024644107 @default.
• W2107255073 cites W2029993898 @default.
• W2107255073 cites W2046900942 @default.
• W2107255073 cites W205114876 @default.
• W2107255073 cites W2056805772 @default.
• W2107255073 cites W2067717482 @default.
• W2107255073 cites W2074438676 @default.
• W2107255073 cites W2077158310 @default.
• W2107255073 cites W2081388746 @default.
• W2107255073 cites W2084935104 @default.
• W2107255073 cites W2087643058 @default.
• W2107255073 cites W2092773063 @default.
• W2107255073 cites W2097730524 @default.
• W2107255073 cites W2100151922 @default.
• W2107255073 cites W2100736304 @default.
• W2107255073 cites W2100974168 @default.
• W2107255073 cites W2104388056 @default.
• W2107255073 cites W2108646369 @default.
• W2107255073 cites W2118994799 @default.
• W2107255073 cites W2119288715 @default.
• W2107255073 cites W2125212735 @default.
• W2107255073 cites W2129479019 @default.
• W2107255073 cites W2133696182 @default.
• W2107255073 cites W2133996321 @default.
• W2107255073 cites W2146052459 @default.
• W2107255073 cites W2152808869 @default.
• W2107255073 cites W2158911776 @default.
• W2107255073 cites W2163493960 @default.
• W2107255073 cites W2416457843 @default.
• W2107255073 cites W96168935 @default.
• W2107255073 doi "https://doi.org/10.4038/jccp.v41i2.3770" @default.
• W2107255073 hasPublicationYear "2011" @default.
• W2107255073 type Work @default.
• W2107255073 sameAs 2107255073 @default.
• W2107255073 citedByCount "1" @default.
• W2107255073 countsByYear W21072550732013 @default.
• W2107255073 crossrefType "journal-article" @default.
• W2107255073 hasAuthorship W2107255073A5054022162 @default.
• W2107255073 hasAuthorship W2107255073A5080471651 @default.
• W2107255073 hasAuthorship W2107255073A5083389526 @default.
• W2107255073 hasAuthorship W2107255073A5089092128 @default.
• W2107255073 hasBestOaLocation W21072550731 @default.
• W2107255073 hasConcept C126322002 @default.
• W2107255073 hasConcept C159654299 @default.
• W2107255073 hasConcept C17991360 @default.
• W2107255073 hasConcept C203014093 @default.
• W2107255073 hasConcept C2775905006 @default.
• W2107255073 hasConcept C2776260265 @default.
• W2107255073 hasConcept C2777077863 @default.
• W2107255073 hasConcept C2777138892 @default.
• W2107255073 hasConcept C2777178219 @default.
• W2107255073 hasConcept C2777226972 @default.
• W2107255073 hasConcept C2777402515 @default.
• W2107255073 hasConcept C2777575956 @default.
• W2107255073 hasConcept C2779123688 @default.
• W2107255073 hasConcept C2779134260 @default.
• W2107255073 hasConcept C2779605438 @default.
• W2107255073 hasConcept C2780132546 @default.
• W2107255073 hasConcept C2780653079 @default.
• W2107255073 hasConcept C2781228260 @default.
• W2107255073 hasConcept C2781290027 @default.
• W2107255073 hasConcept C3008058167 @default.
• W2107255073 hasConcept C524204448 @default.
• W2107255073 hasConcept C71924100 @default.
• W2107255073 hasConceptScore W2107255073C126322002 @default.
• W2107255073 hasConceptScore W2107255073C159654299 @default.
• W2107255073 hasConceptScore W2107255073C17991360 @default.
• W2107255073 hasConceptScore W2107255073C203014093 @default.
• W2107255073 hasConceptScore W2107255073C2775905006 @default.
• W2107255073 hasConceptScore W2107255073C2776260265 @default.
• W2107255073 hasConceptScore W2107255073C2777077863 @default.
• W2107255073 hasConceptScore W2107255073C2777138892 @default.
• W2107255073 hasConceptScore W2107255073C2777178219 @default.
• W2107255073 hasConceptScore W2107255073C2777226972 @default.
• W2107255073 hasConceptScore W2107255073C2777402515 @default.
• W2107255073 hasConceptScore W2107255073C2777575956 @default.
• W2107255073 hasConceptScore W2107255073C2779123688 @default.
• W2107255073 hasConceptScore W2107255073C2779134260 @default.
• W2107255073 hasConceptScore W2107255073C2779605438 @default.

• next